Christian Fiedler

Title: Christian Fiedler: A Pioneer in Adeno-Associated Virus Innovations

Introduction

Christian Fiedler, based in Vienna, Austria, is an accomplished inventor with an impressive portfolio of 18 patents. His innovative work primarily focuses on adeno-associated virus (AAV) formulations and purification methods, contributing to advancements in medical and pharmaceutical fields.

Latest Patents

Among his latest patents, Fiedler has developed formulations for adeno-associated viruses that involve liquid and lyophilized pharmaceutical compositions. These formulations typically consist of 5 mM to 25 mM L-histidine, sodium chloride concentrations ranging from 0 mM to 150 mM, polysorbate 80 at 0.001% to 0.01% (w/v), and sucrose or trehalose within a 1% to 10% (w/v) range. Furthermore, these compositions may also incorporate glycine or mannitol. Fiedler’s patents also cover methods of preparing AAV compositions, treating bleeding disorders in subjects, and optimal storage techniques for these compositions. In addition, he has outlined methods for producing and purifying AAV, providing essential insights into the separation of full AAV capsids from empty ones.

Career Highlights

Fiedler has made significant contributions to the pharmaceutical industry through his roles at reputable companies such as Baxalta GmbH and Takeda Pharmaceutical Company Limited. His expertise in AAV technologies has undoubtedly played a crucial role in the development and enhancement of therapeutic products related to gene therapies and treatments for various medical conditions.

Collaborations

Throughout his career, Christian Fiedler has worked alongside notable colleagues, including Meinhard Hasslacher and Artur Mitterer. These collaborations have facilitated innovation and the successful achievement of his research objectives, ultimately benefiting the scientific community and patients alike.

Conclusion

Christian Fiedler’s extensive patent portfolio and innovative research on adeno-associated viruses exemplify his commitment to advancing pharmaceutical and therapeutic technologies. His work not only enhances our understanding of AAV formulations but also paves the way for potential treatments for various medical disorders, solidifying his position as a leading inventor in the field.